PHASE 0 & I STUDY EXPERIENCE INCLUDE:

  • First-in-Human (FIM)Single Ascending Dose (SAD)
  • Multiple Ascending Dose (MAD)
  • Adaptive/Accelerated Protocols
  • PK, PD, BD
  • Food Effect
  • Drug/Drug Interaction
  • Age & Gender
  • Special Populations with specific diseases(CHF, CRF, Malignancies etc.)
  • Bioavailability/Bioequivalence (For Biosimilar or Generic Version)

PHASE I/II STUDIES:  NHCR will help the sponsor to combine Phase I and Phase II for:

  • Efficacy (response to new treatment)
  • Toxicity (safety, dosage levels)

Location

New Hope Clinical Research
3101 Latrobe Dr
Charlotte, NC 28211

Phone : 980-228-9616
Fax : 980-226-5843

Office Hours

  • Monday – 8:00 am – 5:00 pm
  • Tuesday – 8:00 am – 5:00 pm
  • Wednesday – 8:00 am – 5:00 pm
  • Thursday – 8:00 am – 5:00 pm
  • Friday – 8:00 am – 5:00 pm
  • Saturday – Closed
  • Sunday – Closed

Get In Touch